Two Randomized Trials of Neutralizing Antibodies to Prevent HIV-1 AcquisitionLawrence Corey, Myron S. Cohen, Erica Lazarus et al.|New England Journal of Medicine|2021Cited by 540
Penetration of Tenofovir and Emtricitabine in Mucosal Tissues: Implications for Prevention of HIV-1 TransmissionKristine B. Patterson, Angela D. M. Kashuba, Heather A. Prince et al.|Science Translational Medicine|2011Cited by 350
The spread, treatment, and prevention of HIV-1: evolution of a global pandemicMyron S. Cohen, Joep M. A. Lange, Nick Hellmann et al.|Journal of Clinical Investigation|2008Cited by 308
Effect of Bamlanivimab vs Placebo on Incidence of COVID-19 Among Residents and Staff of Skilled Nursing and Assisted Living FacilitiesMyron S. Cohen, Jason Morris, Ajay Nirula et al.|JAMA|2021Cited by 208
Tail-phase safety, tolerability, and pharmacokinetics of long-acting injectable cabotegravir in HIV-uninfected adults: a secondary analysis of the HPTN 077 trialRaphael J. Landovitz, Craig W. Hendrix, Sue Li et al.|The Lancet HIV|2020Cited by 171